{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T02:44:45Z","timestamp":1789958685296,"version":"4.0.1"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19K07080"],"award-info":[{"award-number":["19K07080"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K07344"],"award-info":[{"award-number":["22K07344"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23H00394"],"award-info":[{"award-number":["23H00394"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["22dm0207073"],"award-info":[{"award-number":["22dm0207073"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["22dm0207073"],"award-info":[{"award-number":["22dm0207073"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["25dk0207073"],"award-info":[{"award-number":["25dk0207073"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020963","name":"Moonshot Research and Development Program","doi-asserted-by":"publisher","award":["JPMJMS2024"],"award-info":[{"award-number":["JPMJMS2024"]}],"id":[{"id":"10.13039\/501100020963","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm Regener"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Alzheimer's disease (AD) is characterized by amyloid \u03b2 (A\u03b2) accumulation in the brain. Recent genome-wide association studies have identified numerous AD risk genes highly expressed in microglia, highlighting their potential role in AD pathogenesis. Although microglia possess phagocytic capacity and have been implicated in A\u03b2 clearance, accumulating evidence suggests their contribution to AD pathogenesis is more complex than initially anticipated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Main body<\/jats:title>\n            <jats:p>This review synthesizes current knowledge on microglial A\u03b2 metabolism in AD, reconciling conflicting data from various studies. We examine evidence supporting the role of microglia in A\u03b2 clearance, including studies on AD risk genes like TREM2 and their impact on microglial phagocytosis. Conversely, we explore findings that challenge this view, such as microglial depletion experiments resulting in unchanged or decreased A\u03b2 accumulation. We propose that the contribution of microglia to A\u03b2 metabolism is context-dependent, varying with disease progression, genetic background, and experimental conditions. Notably, microglia may promote parenchymal amyloid accumulation in early disease stages, while this accumulation-promoting effect may diminish in later stages. We discuss potential mechanisms for this paradoxical effect, including intracellular A\u03b2 aggregation and release of pro-aggregation factors. Additionally, we explore the interplay between microglia-mediated A\u03b2 metabolism and other clearance pathways, such as the glymphatic system, highlighting a potential compensatory relationship between parenchymal amyloid deposition and cerebral amyloid angiopathy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Our review underscores the complex and dynamic role of microglia in AD pathogenesis. Understanding the stage-specific functions of microglia in A\u03b2 metabolism is crucial for developing targeted interventions. Future research should focus on elucidating the mechanisms of microglial functional changes throughout disease progression and determining the pathological significance of these changes. Exploring potential therapeutic strategies that selectively enhance beneficial microglial functions while mitigating their detrimental effects remains an important goal.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s41232-025-00383-4","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T03:30:21Z","timestamp":1748575821000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Unraveling the complex role of microglia in Alzheimer\u2019s disease: amyloid \u03b2 metabolism and plaque formation"],"prefix":"10.1186","volume":"45","author":[{"given":"Sho","family":"Takatori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayuna","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0075-5943","authenticated-orcid":false,"given":"Taisuke","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,30]]},"reference":[{"key":"383_CR1","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe DJ, Hardy J. The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO Mol Med. 2016;8:595\u2013608.","journal-title":"EMBO Mol Med"},{"key":"383_CR2","doi-asserted-by":"crossref","unstructured":"Mawuenyega KG, Sigurdson W, Ovod V, Munsell L, Kasten T, Morris JC, et al. Decreased clearance of CNS beta-amyloid in Alzheimer\u2019s disease. Science. 2010;330(6012):1774.","DOI":"10.1126\/science.1197623"},{"key":"383_CR3","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/ng.1027","volume":"44","author":"R Rademakers","year":"2011","unstructured":"Rademakers R, Baker M, Nicholson AM, Rutherford NJ, Finch N, Soto-Ortolaza A, et al. Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids. Nat Genet. 2011;44:200\u20135.","journal-title":"Nat Genet"},{"key":"383_CR4","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1083\/jcb.201709069","volume":"217","author":"DV Hansen","year":"2018","unstructured":"Hansen DV, Hanson JE, Sheng M. Microglia in Alzheimer\u2019s disease. J Cell Biol. 2018;217:459\u201372.","journal-title":"J Cell Biol"},{"key":"383_CR5","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","volume":"54","author":"C Bellenguez","year":"2022","unstructured":"Bellenguez C, K\u00fc\u00e7\u00fckali F, Jansen IE, Kleineidam L, Moreno-Grau S, Amin N, et al. New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias. Nat Genet. 2022;54:412\u201336.","journal-title":"Nat Genet"},{"key":"383_CR6","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.biopsych.2014.05.006","volume":"77","author":"CM Karch","year":"2015","unstructured":"Karch CM, Goate AM. Alzheimer\u2019s disease risk genes and mechanisms of disease pathogenesis. Biol Psychiatry. 2015;77:43\u201351.","journal-title":"Biol Psychiatry"},{"key":"383_CR7","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/978-3-030-05542-4_5","volume":"1118","author":"S Takatori","year":"2019","unstructured":"Takatori S, Wang W, Iguchi A, Tomita T. Genetic risk factors for alzheimer disease: emerging roles of microglia in disease pathomechanisms. Adv Exp Med Biol. 2019;1118:83\u2013116.","journal-title":"Adv Exp Med Biol"},{"key":"383_CR8","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK, et al. A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell. 2017;169:1276-1290.e17.","journal-title":"Cell"},{"key":"383_CR9","doi-asserted-by":"publisher","first-page":"4386","DOI":"10.1016\/j.cell.2023.08.037","volume":"186","author":"N Sun","year":"2023","unstructured":"Sun N, Victor MB, Park YP, Xiong X, Scannail AN, Leary N, et al. Human microglial state dynamics in Alzheimer\u2019s disease progression. Cell. 2023;186:4386-4403.e29.","journal-title":"Cell"},{"key":"383_CR10","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/s41577-023-00837-1","volume":"23","author":"M Colonna","year":"2023","unstructured":"Colonna M. The biology of TREM receptors. Nat Rev Immunol. 2023;23:580\u201394.","journal-title":"Nat Rev Immunol"},{"key":"383_CR11","doi-asserted-by":"publisher","first-page":"222.e9","DOI":"10.1016\/j.neurobiolaging.2016.07.028","volume":"48","author":"C Pottier","year":"2016","unstructured":"Pottier C, Ravenscroft TA, Brown PH, Finch NA, Baker M, Parsons M, et al. Neurobiology of aging TYROBP genetic variants in early-onset Alzheimer\u2019s disease. Neurobiol Aging. 2016;48:222.e9-222.e15.","journal-title":"Neurobiol Aging"},{"key":"383_CR12","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.cell.2015.01.049","volume":"160","author":"Y Wang","year":"2015","unstructured":"Wang Y, Cella M, Mallinson K, Ulrich JD, Young KL, Robinette ML, et al. TREM2 lipid sensing sustains the microglial response in an Alzheimer\u2019s disease model. Cell. 2015;160:1061\u201371.","journal-title":"Cell"},{"key":"383_CR13","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1084\/jem.20151948","volume":"213","author":"Y Wang","year":"2016","unstructured":"Wang Y, Ulland TK, Ulrich JD, Song W, Tzaferis JA, Hole JT, et al. TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques. J Exp Med. 2016;213:667\u201375.","journal-title":"J Exp Med"},{"key":"383_CR14","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.neuron.2019.06.010","volume":"103","author":"A Griciuc","year":"2019","unstructured":"Griciuc A, Patel S, Federico AN, Choi SH, Innes BJ, Oram MK, et al. TREM2 acts downstream of CD33 in modulating microglial pathology in Alzheimer\u2019s disease. Neuron. 2019;103:820-835.e7.","journal-title":"Neuron"},{"key":"383_CR15","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1084\/jem.20142322","volume":"212","author":"TR Jay","year":"2015","unstructured":"Jay TR, Miller CM, Cheng PJ, Graham LC, Bemiller S, Broihier ML, et al. TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer\u2019s disease mouse models. J Exp Med. 2015;212:287\u201395.","journal-title":"J Exp Med"},{"key":"383_CR16","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1523\/JNEUROSCI.2110-16.2016","volume":"37","author":"TR Jay","year":"2017","unstructured":"Jay TR, Hirsch AM, Broihier ML, Miller CM, Neilson LE, Ransohoff RM, Lamb BT, et al. Disease progression-dependent effects of TREM2 deficiency in a mouse model of Alzheimer\u2019s disease. J Neurosci. 2017;37:637\u201347.","journal-title":"J Neurosci"},{"key":"383_CR17","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/s41593-018-0296-9","volume":"22","author":"S Parhizkar","year":"2019","unstructured":"Parhizkar S, Arzberger T, Brendel M, Kleinberger G, Deussing M, Focke C, Nuscher B, et al. Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE. Nat Neurosci. 2019;22:191\u2013204.","journal-title":"Nat Neurosci"},{"issue":"8","key":"383_CR18","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/s41593-019-0433-0","volume":"22","author":"CEG Leyns","year":"2019","unstructured":"Leyns CEG, Gratuze M, Narasimhan S, Jain N, Koscal LJ, Jiang H, et al. TREM2 function impedes tau seeding in neuritic plaques. Nature Neurosci. 2019;22(8):1217\u201322.","journal-title":"Nature Neurosci"},{"key":"383_CR19","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1523\/JNEUROSCI.1871-19.2019","volume":"40","author":"WJ Meilandt","year":"2020","unstructured":"Meilandt WJ, Ngu H, Gogineni A, Lalehzadeh G, Lee SH, Srinivasan K, Imperio J, et al. Trem2 deletion reduces late-stage amyloid plaque accumulation, elevates the A\u03b242:A\u03b240 ratio, and exacerbates axonal dystrophy and dendritic spine loss in the PS2APP Alzheimer\u2019s mouse model. J Neurosci. 2020;40:1956\u201374.","journal-title":"J Neurosci"},{"key":"383_CR20","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.neuron.2018.02.002","volume":"97","author":"CYD Lee","year":"2018","unstructured":"Lee CYD, Daggett A, Gu X, Jiang LL, Langfelder P, Li X, et al. Elevated TREM2 gene dosage reprograms microglia responsivity and ameliorates pathological phenotypes in Alzheimer\u2019s disease models. Neuron. 2018;97:1032-1048.e5.","journal-title":"Neuron"},{"key":"383_CR21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.celrep.2022.110883","volume":"39","author":"R Dhandapani","year":"2022","unstructured":"Dhandapani R, Neri M, Bernhard M, Brzak I, Schweizer T, Rudin S, et al. Sustained Trem2 stabilization accelerates microglia heterogeneity and A\u03b2 pathology in a mouse model of Alzheimer\u2019s disease. Cell Rep. 2022;39:39.","journal-title":"Cell Rep."},{"key":"383_CR22","doi-asserted-by":"publisher","first-page":"e20212479","DOI":"10.1084\/jem.20212479","volume":"219","author":"N Zhao","year":"2022","unstructured":"Zhao N, Qiao W, Li F, Ren Y, Zheng J, Martens YA, et al. Elevating microglia TREM2 reduces amyloid seeding and suppresses disease-associated microglia. J Exp Med. 2022;219:e20212479.","journal-title":"J Exp Med"},{"key":"383_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040124","volume":"4","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Prinz M, Stagi M, Chechneva O, Neumann H. TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis. PLoS Med. 2007;4: e124.","journal-title":"PLoS Med"},{"key":"383_CR24","doi-asserted-by":"publisher","first-page":"243ra86","DOI":"10.1126\/scitranslmed.3009093","volume":"6","author":"G Kleinberger","year":"2014","unstructured":"Kleinberger G, Yamanishi Y, Su\u00e1rez-Calvet M, Czirr E, Lohmann E, Cuyvers E, et al. TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis. Sci Transl Med. 2014;6:243ra86.","journal-title":"Sci Transl Med."},{"key":"383_CR25","doi-asserted-by":"publisher","first-page":"992","DOI":"10.15252\/emmm.201606370","volume":"8","author":"X Xiang","year":"2016","unstructured":"Xiang X, Werner G, Bohrmann B, Liesz A, Mazaheri F, Capell A, et al. TREM2 deficiency reduces the efficacy of immunotherapeutic amyloid clearance. EMBO Mol Med. 2016;8:992\u20131004.","journal-title":"EMBO Mol Med"},{"key":"383_CR26","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.neuron.2018.01.031","volume":"97","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Wu X, Li X, Jiang LL, Gui X, Liu Y, Sun Y, et al. TREM2 is a receptor for \u03b2-amyloid that mediates microglial function. Neuron. 2018;97:1023-1031.e7.","journal-title":"Neuron"},{"key":"383_CR27","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2114486119","volume":"119","author":"KD Belsare","year":"2022","unstructured":"Belsare KD, Wu H, Mondal D, Bond A, Castillo E, Jin J, et al. Soluble TREM2 inhibits secondary nucleation of A\u03b2 fibrillization and enhances cellular uptake of fibrillar A\u03b2. Proc Natl Acad Sci U S A. 2022;119: e2114486119.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"383_CR28","doi-asserted-by":"publisher","first-page":"11118","DOI":"10.1038\/s41598-017-11634-x","volume":"7","author":"S-M Kim","year":"2017","unstructured":"Kim S-M, Mun B-R, Lee S-J, Joh Y, Lee H-Y, Ji K-Y, et al. TREM2 promotes A\u03b2 phagocytosis by upregulating C\/EBP\u03b1-dependent CD36 expression in microglia. Sci Rep. 2017;7:11118.","journal-title":"Sci Rep"},{"key":"383_CR29","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1016\/j.cell.2022.09.030","volume":"185","author":"H Ennerfelt","year":"2022","unstructured":"Ennerfelt H, Frost EL, Shapiro Daniel A, Holliday C, Zengeler KE, Voithofer G, Bolte AC, et al. SYK coordinates neuroprotective microglial responses in neurodegenerative disease. Cell. 2022;185:4135-4152.e22.","journal-title":"Cell"},{"key":"383_CR30","doi-asserted-by":"publisher","first-page":"4153","DOI":"10.1016\/j.cell.2022.09.033","volume":"185","author":"S Wang","year":"2022","unstructured":"Wang S, Sudan R, Peng V, Zhou Y, Du S, Yuede CM, et al. TREM2 drives microglia response to amyloid-\u03b2 via SYK-dependent and -independent pathways. Cell. 2022;185:4153-4169.e19.","journal-title":"Cell"},{"key":"383_CR31","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.neuron.2016.05.003","volume":"90","author":"P Yuan","year":"2016","unstructured":"Yuan P, Condello C, Keene CD, Wang Y, Bird TD, Paul SM, et al. TREM2 haplodeficiency in mice and humans impairs the microglia barrier function leading to decreased amyloid compaction and severe axonal dystrophy. Neuron. 2016;90:724\u201339.","journal-title":"Neuron"},{"key":"383_CR32","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.neuron.2021.02.010","volume":"109","author":"S-H Lee","year":"2021","unstructured":"Lee S-H, Meilandt WJ, Xie L, Gandham VD, Ngu H, Barck KH, et al. Trem2 restrains the enhancement of tau accumulation and neurodegeneration by \u03b2-amyloid pathology. Neuron. 2021;109:1283-1301.e6.","journal-title":"Neuron"},{"key":"383_CR33","doi-asserted-by":"publisher","first-page":"e20200785","DOI":"10.1084\/jem.20200785","volume":"217","author":"S Wang","year":"2020","unstructured":"Wang S, Mustafa M, Yuede CM, Salazar SV, Kong P, Long H, et al. Anti-human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer\u2019s disease model. J Exp Med. 2020;217:e20200785.","journal-title":"J Exp Med"},{"key":"383_CR34","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s12974-020-01915-0","volume":"17","author":"BR Price","year":"2020","unstructured":"Price BR, Sudduth TL, Weekman Erica M, Johnson S, Hawthorne D, Woolums A, Wilcock DM. Therapeutic Trem2 activation ameliorates amyloid-beta deposition and improves cognition in the 5XFAD model of amyloid deposition. J Neuroinflammation. 2020;17:238.","journal-title":"J Neuroinflammation"},{"key":"383_CR35","doi-asserted-by":"publisher","first-page":"e11227","DOI":"10.15252\/emmm.201911227","volume":"12","author":"K Schlepckow","year":"2020","unstructured":"Schlepckow K, Monroe KM, Kleinberger G, Cantuti-Castelvetri L, Parhizkar S, Xia D, Willem M, et al. Enhancing protective microglial activities with a dual function TREM2 antibody to the stalk region. EMBO Mol Med. 2020;12:e11227.","journal-title":"EMBO Mol Med"},{"key":"383_CR36","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1002\/glia.22486","volume":"61","author":"AM Smith","year":"2013","unstructured":"Smith AM, Gibbons HM, Oldfield RL, Bergin PM, Mee EW, Faull RLM, et al. The transcription factor PU.1 is critical for viability and function of human brain microglia. Glia. 2013;61:929\u201342.","journal-title":"Glia."},{"key":"383_CR37","doi-asserted-by":"crossref","unstructured":"Huang KL, The International Genomics of Alzheimer\u2019s Project, Marcora E, Pimenova AA, Di Narzo AF, Kapoor M, et al. A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer\u2019s disease. Nat Neurosci. 2017;20:1052\u201361.","DOI":"10.1038\/nn.4587"},{"key":"383_CR38","doi-asserted-by":"publisher","first-page":"eadj9052","DOI":"10.1126\/scitranslmed.adj9052","volume":"16","author":"J Hou","year":"2024","unstructured":"Hou J, Chen Y, Cai Z, Seong Heo Gyu, Yuede CM, Wang Z, Lin K, et al. Antibody-mediated targeting of human microglial leukocyte Ig-like receptor B4 attenuates amyloid pathology in a mouse model. Sci Transl Med. 2024;16:eadj9052.","journal-title":"Sci Transl Med"},{"key":"383_CR39","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1002\/alz.12849","volume":"19","author":"PB-C Lin","year":"2023","unstructured":"Lin PB-C, Tsai AP-Y, Soni D, Lee-Gosselin A, Moutinho M, Puntambekar SS, et al. INPP5D deficiency attenuates amyloid pathology in a mouse model of Alzheimer\u2019s disease. Alzheimers Dement. 2023;19:2528\u201337.","journal-title":"Alzheimers Dement."},{"key":"383_CR40","doi-asserted-by":"publisher","first-page":"106375","DOI":"10.1016\/j.isci.2023.106375","volume":"26","author":"A Iguchi","year":"2023","unstructured":"Iguchi A, Takatori S, Kimura S, Muneto H, Wang K, Etani H, et al. INPP5D modulates TREM2 loss-of-function phenotypes in a \u03b2-amyloidosis mouse model. iScience. 2023;26:106375.","journal-title":"iScience"},{"key":"383_CR41","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1002\/alz.12821","volume":"19","author":"EL Castranio","year":"2023","unstructured":"Castranio EL, Hasel P, Haure-Mirande JV, Ramirez Jimenez AV, Hamilton BW, Kim RD, Glabe CG, et al. Microglial INPP5D limits plaque formation and glial reactivity in the PSAPP mouse model of Alzheimer\u2019s disease. Alzheimers Dement. 2023;19:2239\u201352.","journal-title":"Alzheimers Dement"},{"key":"383_CR42","doi-asserted-by":"publisher","first-page":"4908","DOI":"10.1002\/alz.13089","volume":"19","author":"JD Samuels","year":"2023","unstructured":"Samuels JD, Moore KA, Ennerfelt Hannah E, Johnson AM, Walsh AE, Price Richard J, Lukens JR. The Alzheimer\u2019s disease risk factor INPP5D restricts neuroprotective microglial responses in amyloid beta-mediated pathology. Alzheimers Dement. 2023;19:4908\u201321.","journal-title":"Alzheimers Dement"},{"key":"383_CR43","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1038\/s41590-023-01627-6","volume":"24","author":"Z Yin","year":"2023","unstructured":"Yin Z, Rosenzweig N, Kleemann KL, Zhang X, Brand\u00e3o W, Margeta Milica A, Schroeder C, et al. APOE4 impairs the microglial response in Alzheimer\u2019s disease by inducing TGF\u03b2-mediated checkpoints. Nat Immunol. 2023;24:1839\u201353.","journal-title":"Nat Immunol"},{"key":"383_CR44","doi-asserted-by":"publisher","first-page":"eabe3954","DOI":"10.1126\/sciadv.abe3954","volume":"7","author":"H Karahan","year":"2021","unstructured":"Karahan H, Smith DC, Kim B, Dabin LC, Al-Amin MM, Wijeratne HRS, et al. Deletion of Abi3 gene locus exacerbates neuropathological features of Alzheimer\u2019s disease in a mouse model of A\u03b2 amyloidosis. Sci Adv. 2021;7:eabe3954.","journal-title":"Sci Adv."},{"key":"383_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1102530","volume":"14","author":"H Karahan","year":"2023","unstructured":"Karahan H, Smith DC, Kim B, McCord B, Mantor J, John SK, et al. The effect of Abi3 locus deletion on the progression of Alzheimer\u2019s disease-related pathologies. Front Immunol. 2023;14: 1102530.","journal-title":"Front Immunol"},{"key":"383_CR46","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13195-022-01044-1","volume":"14","author":"KR Ibanez","year":"2022","unstructured":"Ibanez KR, McFarland KN, Phillips J, Allen M, Lessard CB, Zobel L, De La Cruz EG, et al. Deletion of Abi3\/Gngt2 influences age-progressive amyloid \u03b2 and tau pathologies in distinctive ways. Alzheimer\u2019s Res Ther. 2022;14:104.","journal-title":"Alzheimer\u2019s Res Ther"},{"key":"383_CR47","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/382716a0","volume":"382","author":"J El Khoury","year":"1996","unstructured":"El Khoury J, Hickman SE, Thomas CA, Cao L, Silverstein SC, Loike JD. Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils. Nature. 1996;382:716\u20139.","journal-title":"Nature"},{"key":"383_CR48","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/382685a0","volume":"382","author":"SD Yan","year":"1996","unstructured":"Yan SD, Chen X, Fu J, Chen M, Zhu H, Roher A, et al. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer\u2019s disease. Nature. 1996;382:685\u201391.","journal-title":"Nature"},{"key":"383_CR49","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0002-9440(10)64354-4","volume":"160","author":"IS Coraci","year":"2002","unstructured":"Coraci IS, Husemann J, Berman JW, Hulette C, Dufour JH, Campanella GK, et al. CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer\u2019s disease brains and can mediate production of reactive oxygen species in response to \u03b2-amyloid fibrils. Am J Pathol. 2002;160:101\u201312.","journal-title":"Am J Pathol"},{"key":"383_CR50","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1523\/JNEUROSCI.23-07-02665.2003","volume":"23","author":"ME Bamberger","year":"2003","unstructured":"Bamberger ME, Harris ME, McDonald Douglas R, Husemann J, Landreth GE. A cell surface receptor complex for fibrillar \u03b2-amyloid mediates microglial activation. J Neurosci. 2003;23:2665\u201374.","journal-title":"J Neurosci"},{"key":"383_CR51","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1084\/jem.20021546","volume":"197","author":"JB El Khoury","year":"2003","unstructured":"El Khoury JB, Moore KJ, Means TK, Leung J, Terada K, Toft M, et al. CD36 mediates the innate host response to beta-amyloid. J Exp Med. 2003;197:1657\u201366.","journal-title":"J Exp Med"},{"key":"383_CR52","doi-asserted-by":"publisher","first-page":"20816","DOI":"10.1073\/pnas.1005888107","volume":"107","author":"K Thanopoulou","year":"2010","unstructured":"Thanopoulou K, Fragkouli A, Stylianopoulou F, Georgopoulos S. Scavenger receptor class B type I (SR-BI) regulates perivascular macrophages and modifies amyloid pathology in an Alzheimer\u2019s mouse model. Proc Natl Acad Sci U S A. 2010;107:20816\u201321.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"383_CR53","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1038\/ncomms3030","volume":"4","author":"D Frenkel","year":"2013","unstructured":"Frenkel D, Wilkinson K, Zhao L, Hickman SE, Means TK, Puckett L, et al. Scara1 deficiency impairs clearance of soluble amyloid-\u03b2 by mononuclear phagocytes and accelerates Alzheimer\u2019s-like disease progression. Nat Commun. 2013;4:2030.","journal-title":"Nat Commun"},{"key":"383_CR54","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/S0002-9440(10)65489-2","volume":"155","author":"F Huang","year":"1999","unstructured":"Huang F, Buttini M, Wyss-Coray T, McConlogue L, Kodama T, Pitas RE, et al. Elimination of the class A scavenger receptor does not affect amyloid plaque formation or neurodegeneration in transgenic mice expressing human amyloid protein precursors. Am J Pathol. 1999;155:1741\u20137.","journal-title":"Am J Pathol"},{"key":"383_CR55","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41590-021-00913-5","volume":"22","author":"Y Huang","year":"2021","unstructured":"Huang Y, Happonen KE, Burrola PG, O\u2019Connor C, Hah N, Huang L, et al. Microglia use TAM receptors to detect and engulf amyloid \u03b2 plaques. Nat Immunol. 2021;22:586\u201394.","journal-title":"Nat Immunol"},{"key":"383_CR56","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.neuron.2022.10.021","volume":"111","author":"J Hu","year":"2023","unstructured":"Hu J, Chen Q, Zhu H, Hou L, Liu W, Yang Q, et al. Microglial Piezo1 senses A\u03b2 fibril stiffness to restrict Alzheimer\u2019s disease. Neuron. 2023;111:15-29.e8.","journal-title":"Neuron"},{"key":"383_CR57","doi-asserted-by":"publisher","first-page":"17091","DOI":"10.1523\/JNEUROSCI.4403-10.2010","volume":"30","author":"Z Liu","year":"2010","unstructured":"Liu Z, Condello C, Schain A, Harb R, Grutzendler J. CX3CR1 in microglia regulates brain amyloid deposition through selective protofibrillar amyloid-\u03b2 phagocytosis. J Neurosci. 2010;30:17091\u2013101.","journal-title":"J Neurosci"},{"key":"383_CR58","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2303760120","volume":"120","author":"H Ennerfelt","year":"2023","unstructured":"Ennerfelt H, Holliday C, Shapiro DA, Zengeler KE, Bolte AC, Ulland TK, et al. CARD9 attenuates A\u03b2 pathology and modifies microglial responses in an Alzheimer\u2019s disease mouse model. Proc Natl Acad Sci U S A. 2023;120: e2303760120.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"383_CR59","doi-asserted-by":"publisher","unstructured":"Etani H, Takatori S, Wang W, Omi J, Akahori A, Watanabe H, et al. Selective agonism of GPR34 stimulates microglial uptake and clearance of amyloid \u03b2 fibrils. bioRxiv. 2024. https:\/\/doi.org\/10.1101\/2024.05.08.593262.","DOI":"10.1101\/2024.05.08.593262"},{"key":"383_CR60","doi-asserted-by":"publisher","first-page":"4252","DOI":"10.1523\/JNEUROSCI.5572-08.2009","volume":"29","author":"S Mandrekar","year":"2009","unstructured":"Mandrekar S, Jiang Q, Lee CYD, Koenigsknecht-Talboo J, Holtzman DM, Landreth GE. Microglia mediate the clearance of soluble Abeta through fluid phase macropinocytosis. J Neurosci. 2009;29:4252\u201362.","journal-title":"J Neurosci"},{"key":"383_CR61","doi-asserted-by":"publisher","first-page":"6641","DOI":"10.1074\/jbc.272.10.6641","volume":"272","author":"WQ Qiu","year":"1997","unstructured":"Qiu WQ, Ye Z, Kholodenko D, Seubert P, Selkoe DJ. Degradation of amyloid \u03b2-protein by a metalloprotease secreted by microglia and other neural and non-neural cells. J Biol Chem. 1997;272:6641\u20136.","journal-title":"J Biol Chem"},{"key":"383_CR62","doi-asserted-by":"publisher","first-page":"37405","DOI":"10.1074\/jbc.M110.149468","volume":"285","author":"IY Tamboli","year":"2010","unstructured":"Tamboli IY, Barth E, Christian L, Siepmann M, Kumar S, Singh S, et al. Statins promote the degradation of extracellular amyloid \u03b2-peptide by microglia via stimulation of exosome-associated insulin-degrading enzyme (IDE) secretion. J Biol Chem. 2010;285:37405\u201314.","journal-title":"J Biol Chem"},{"key":"383_CR63","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nature11729","volume":"493","author":"MT Heneka","year":"2013","unstructured":"Heneka MT, Kummer MP, Stutz A, Delekate A, Schwartz S, Vieira-Saecker A, et al. NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice. Nature. 2013;493:674\u20138.","journal-title":"Nature"},{"key":"383_CR64","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41586-021-03734-6","volume":"595","author":"CS McAlpine","year":"2021","unstructured":"McAlpine CS, Park J, Griciuc A, Kim E, Choi SH, Iwamoto Y, et al. Astrocytic interleukin-3 programs microglia and limits Alzheimer\u2019s disease. Nature. 2021;595:701\u20136.","journal-title":"Nature"},{"key":"383_CR65","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.immuni.2021.12.001","volume":"55","author":"D He","year":"2022","unstructured":"He D, Xu H, Zhang H, Tang R, Lan Y, Xing R, et al. Disruption of the IL-33-ST2-AKT signaling axis impairs neurodevelopment by inhibiting microglial metabolic adaptation and phagocytic function. Immunity. 2022;55:159-173.e9.","journal-title":"Immunity"},{"key":"383_CR66","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/s43587-023-00491-1","volume":"3","author":"S-F Lau","year":"2023","unstructured":"Lau S-F, Wu W, Wong HY, Ouyang L, Qiao Y, Xu J, et al. The VCAM1-ApoE pathway directs microglial chemotaxis and alleviates Alzheimer\u2019s disease pathology. Nat Aging. 2023;3:1219\u201336.","journal-title":"Nat Aging"},{"key":"383_CR67","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1002\/glia.22331","volume":"60","author":"H Fu","year":"2012","unstructured":"Fu H, Liu B, Frost JL, Hong S, Jin M, Ostaszewski B, et al. Complement component C3 and complement receptor type 3 contribute to the phagocytosis and clearance of fibrillar A\u03b2 by microglia. Glia. 2012;60:993\u20131003.","journal-title":"Glia"},{"key":"383_CR68","doi-asserted-by":"publisher","first-page":"e20200895","DOI":"10.1084\/jem.20200895","volume":"219","author":"HB Dodiya","year":"2022","unstructured":"Dodiya HB, Lutz HL, Weigle IQ, Patel P, Michalkiewicz J, Roman-Santiago CJ, et al. Gut microbiota-driven brain A\u03b2 amyloidosis in mice requires microglia. J Exp Med. 2022;219:e20200895.","journal-title":"J Exp Med"},{"key":"383_CR69","doi-asserted-by":"publisher","first-page":"10","DOI":"10.7554\/eLife.59826","volume":"10","author":"AV Colombo","year":"2021","unstructured":"Colombo AV, Sadler RK, Llovera G, Singh V, Roth S, Heindl S, et al. Microbiota-derived short chain fatty acids modulate microglia and promote A\u03b2 plaque deposition. Elife. 2021;10:10.","journal-title":"Elife."},{"key":"383_CR70","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/s41586-019-1088-4","volume":"568","author":"JV Pluvinage","year":"2019","unstructured":"Pluvinage J V, Haney MS, Smith Benjamin A H and Sun J, Iram T, Bonanno L, Li Lulin and Lee DP, et al. CD22 blockade restores homeostatic microglial phagocytosis in ageing brains. Nature. 2019;568:187\u201392.","journal-title":"Nature"},{"key":"383_CR71","doi-asserted-by":"publisher","first-page":"19471","DOI":"10.1038\/s41598-022-21920-y","volume":"12","author":"AL Thomas","year":"2022","unstructured":"Thomas AL, Lehn MA, Janssen EM, Hildeman DA, Chougnet CA. Naturally-aged microglia exhibit phagocytic dysfunction accompanied by gene expression changes reflective of underlying neurologic disease. Sci Rep. 2022;12:19471.","journal-title":"Sci Rep"},{"key":"383_CR72","doi-asserted-by":"publisher","first-page":"873","DOI":"10.3233\/ADR-230025","volume":"7","author":"DA Loeffler","year":"2023","unstructured":"Loeffler DA. Antibody-mediated clearance of brain amyloid-\u03b2: mechanisms of action, effects of natural and monoclonal anti-A\u03b2 antibodies, and downstream effects. J Alzheimers Dis Rep. 2023;7:873\u201399.","journal-title":"J Alzheimers Dis Rep"},{"key":"383_CR73","first-page":"287","volume":"7","author":"HM Wisniewski","year":"1990","unstructured":"Wisniewski HM, Vorbrodt AW, Wegiel J, Morys J, Lossinsky AS. Ultrastructure of the cells forming amyloid fibers in Alzheimer disease and scrapie. Am J Med Genet Suppl. 1990;7:287\u201397.","journal-title":"Am J Med Genet Suppl"},{"key":"383_CR74","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/BF00227813","volume":"84","author":"J Frackowiak","year":"1992","unstructured":"Frackowiak J, Wisniewski HM, Wegiel J, Merz GS, Iqbal K, Wang KC. Ultrastructure of the microglia that phagocytose amyloid and the microglia that produce\u202f?-amyloid fibrils. Acta Neuropathol. 1992;84:225.","journal-title":"Acta Neuropathol"},{"key":"383_CR75","doi-asserted-by":"publisher","first-page":"29390","DOI":"10.1074\/jbc.272.46.29390","volume":"272","author":"DM Paresce","year":"1997","unstructured":"Paresce DM, Chung H, Maxfield FR. Slow degradation of aggregates of the Alzheimer\u2019s disease amyloid \u03b2-protein by microglial cells. J Biol Chem. 1997;272:29390\u20137.","journal-title":"J Biol Chem"},{"key":"383_CR76","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13024-021-00440-9","volume":"16","author":"K Clayton","year":"2021","unstructured":"Clayton K, Delpech JC, Herron S, Iwahara N, Ericsson M, Saito T, Saido TC, et al. Plaque associated microglia hyper-secrete extracellular vesicles and accelerate tau propagation in a humanized APP mouse model. Mol Neurodegener. 2021;16:18.","journal-title":"Mol Neurodegener"},{"key":"383_CR77","doi-asserted-by":"publisher","first-page":"10634","DOI":"10.1038\/s41467-024-54779-w","volume":"15","author":"N Balig\u00e1cs","year":"2024","unstructured":"Balig\u00e1cs N, Albertini G, Borrie SC, Serneels L, Pridans C, Balusu S, et al. Homeostatic microglia initially seed and activated microglia later reshape amyloid plaques in Alzheimer\u2019s Disease. Nat Commun. 2024;15:10634.","journal-title":"Nat Commun"},{"key":"383_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.104956","volume":"142","author":"BT Casali","year":"2020","unstructured":"Casali BT, MacPherson KP, Reed-Geaghan EG, Landreth GE. Microglia depletion rapidly and reversibly alters amyloid pathology by modification of plaque compaction and morphologies. Neurobiol Dis. 2020;142: 104956.","journal-title":"Neurobiol Dis"},{"key":"383_CR79","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12974-015-0366-9","volume":"12","author":"NN Dagher","year":"2015","unstructured":"Dagher NN, Najafi AR, Kayala KM, Elmore MRP, White TE, Medeiros R, West BL, Green KN. Colony-stimulating factor 1 receptor inhibition prevents microglial plaque association and improves cognition in 3xTg-AD mice. J Neuroinflammation. 2015;12:139.","journal-title":"J Neuroinflammation"},{"key":"383_CR80","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1038\/nn.2432","volume":"12","author":"SA Grathwohl","year":"2009","unstructured":"Grathwohl SA, K\u00e4lin RE, Bolmont T, Prokop S, Winkelmann G, Kaeser SA, Odenthal J, Radde R, et al. Formation and maintenance of Alzheimer\u2019s disease beta-amyloid plaques in the absence of microglia. Nat Neurosci. 2009;12:1361\u20133.","journal-title":"Nat Neurosci"},{"issue":"Pt 3","key":"383_CR81","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1093\/brain\/awv379","volume":"139","author":"A Olmos-Alonso","year":"2016","unstructured":"Olmos-Alonso A, Schetters STT, Sarmi Sri, Askew K, Mancuso R, Vargas-Caballero M, Holscher C, et al. Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer\u2019s-like pathology. Brain. 2016;139(Pt 3):891\u2013907.","journal-title":"Brain"},{"key":"383_CR82","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1084\/jem.20150479","volume":"212","author":"S Prokop","year":"2015","unstructured":"Prokop S, Miller KR, Drost N, Handrick S, Mathur V, Luo J, et al. Impact of peripheral myeloid cells on amyloid-\u03b2 pathology in Alzheimer\u2019s disease-like mice. J Exp Med. 2015;212:1811\u20138.","journal-title":"J Exp Med"},{"key":"383_CR83","doi-asserted-by":"publisher","first-page":"5553","DOI":"10.3390\/ijms21155553","volume":"21","author":"Y Son","year":"2020","unstructured":"Son Y, Jeong YJ, Shin NR, Jong Oh Se, Nam KR, Choi HD, Choi JY, et al. Inhibition of colony-stimulating factor 1 receptor by PLX3397 prevents amyloid beta pathology and rescues dopaminergic signaling in aging 5xFAD mice. Int J Mol Sci. 2020;21:5553.","journal-title":"Int J Mol Sci"},{"key":"383_CR84","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13024-018-0244-x","volume":"13","author":"J Sosna","year":"2018","unstructured":"Sosna J, Philipp S, Albay R, Reyes-Ruiz JM, Baglietto-Vargas D, LaFerla FM, et al. Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer\u2019s disease. Mol Neurodegener. 2018;13:11.","journal-title":"Mol Neurodegener"},{"key":"383_CR85","doi-asserted-by":"publisher","first-page":"3758","DOI":"10.1038\/s41467-019-11674-z","volume":"10","author":"E Spangenberg","year":"2019","unstructured":"Spangenberg E, Severson PL, Hohsfield LA, Crapser J, Zhang J, Burton EA, et al. Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer\u2019s disease model. Nat Commun. 2019;10:3758.","journal-title":"Nat Commun"},{"issue":"Pt 4","key":"383_CR86","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1093\/brain\/aww016","volume":"139","author":"EE Spangenberg","year":"2016","unstructured":"Spangenberg EE, Lee RJ, Najafi Allison R, Rice RA, Elmore MRP, Blurton-Jones M, West BL, et al. Eliminating microglia in Alzheimer\u2019s mice prevents neuronal loss without modulating amyloid-\u03b2 pathology. Brain. 2016;139(Pt 4):1265\u201381.","journal-title":"Brain"},{"key":"383_CR87","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13024-017-0188-6","volume":"12","author":"R Zhao","year":"2017","unstructured":"Zhao R, Hu W, Tsai J, Li W, Gan W-B. Microglia limit the expansion of \u03b2-amyloid plaques in a mouse model of Alzheimer\u2019s disease. Mol Neurodegener. 2017;12:47.","journal-title":"Mol Neurodegener"},{"key":"383_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110961","volume":"39","author":"S Kiani Shabestari","year":"2022","unstructured":"Kiani Shabestari S, Morabito S, Danhash EP, McQuade A, Sanchez JR, Miyoshi E, et al. Absence of microglia promotes diverse pathologies and early lethality in Alzheimer\u2019s disease mice. Cell Rep. 2022;39: 110961.","journal-title":"Cell Rep"},{"key":"383_CR89","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/ni.2639","volume":"14","author":"FJ Sheedy","year":"2013","unstructured":"Sheedy FJ, Grebe A, Rayner KJ, Kalantari P, Ramkhelawon B, Carpenter SB, Becker CE, et al. CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation. Nat Immunol. 2013;14:812\u201320.","journal-title":"Nat Immunol"},{"key":"383_CR90","doi-asserted-by":"publisher","first-page":"5220","DOI":"10.1038\/s41467-021-25344-6","volume":"12","author":"R Bassil","year":"2021","unstructured":"Bassil R, Shields K, Granger K, Zein I, Ng S, Chih B. Improved modeling of human AD with an automated culturing platform for iPSC neurons, astrocytes and microglia. Nat Commun. 2021;12:5220.","journal-title":"Nat Commun"},{"key":"383_CR91","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41593-021-00951-0","volume":"25","author":"P d\u2019Errico","year":"2022","unstructured":"d\u2019Errico P, Ziegler-Waldkirch S, Aires V, Hoffmann P, Mez\u00f6 C, Erny D, et al. Microglia contribute to the propagation of A\u03b2 into unaffected brain tissue. Nat Neurosci. 2022;25:20\u20135.","journal-title":"Nat Neurosci"},{"key":"383_CR92","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1016\/j.immuni.2024.09.014","volume":"57","author":"S Kaji","year":"2024","unstructured":"Kaji S, Berghoff SA, Spieth L, Schlaphoff L, Sasmita AO, Vitale S, et al. Apolipoprotein E aggregation in microglia initiates Alzheimer\u2019s disease pathology by seeding \u03b2-amyloidosis. Immunity. 2024;57:2651.","journal-title":"Immunity"},{"key":"383_CR93","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/nature25158","volume":"552","author":"C Venegas","year":"2017","unstructured":"Venegas C, Kumar S, Franklin BS, Dierkes T, Brinkschulte R, Tejera D, et al. Microglia-derived ASC specks cross-seed amyloid-\u03b2 in Alzheimer\u2019s disease. Nature. 2017;552:355\u201361.","journal-title":"Nature"},{"key":"383_CR94","doi-asserted-by":"publisher","first-page":"147ra111","DOI":"10.1126\/scitranslmed.3003748","volume":"4","author":"JJ Iliff","year":"2012","unstructured":"Iliff JJ, Wang M, Liao Y, Plogg BA, Peng W, Gundersen GA, et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid \u03b2. Sci Transl Med. 2012;4:147ra111.","journal-title":"Sci Transl Med."},{"key":"383_CR95","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/87945","volume":"7","author":"T Wyss-Coray","year":"2001","unstructured":"Wyss-Coray T, Lin C, Yan F, Yu GQ, Rohde M, McConlogue L, et al. TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice. Nat Med. 2001;7:612\u20138.","journal-title":"Nat Med"},{"key":"383_CR96","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s40478-015-0250-y","volume":"3","author":"F Liao","year":"2015","unstructured":"Liao F, Zhang TJ, Jiang H, Lefton KB, Robinson GO, Vassar R, et al. Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models. Acta Neuropathol Commun. 2015;3:70.","journal-title":"Acta Neuropathol Commun"},{"key":"383_CR97","doi-asserted-by":"publisher","first-page":"E6962","DOI":"10.1073\/pnas.1701137114","volume":"114","author":"AM Wojtas","year":"2017","unstructured":"Wojtas AM, Kang SS, Olley Benjamin M, Gatherer M, Shinohara M, Lozano PA, Liu C-C, et al. Loss of clusterin shifts amyloid deposition to the cerebrovasculature via disruption of perivascular drainage pathways. Proc Natl Acad Sci U S A. 2017;114:E6962\u201371.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"383_CR98","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13195-020-00688-1","volume":"12","author":"W Feng","year":"2020","unstructured":"Feng W, Zhang Y, Wang Z, Xu H, Wu T, Marshall C, et al. Microglia prevent beta-amyloid plaque formation in the early stage of an Alzheimer\u2019s disease mouse model with suppression of glymphatic clearance. Alzheimers Res Ther. 2020;12:125.","journal-title":"Alzheimers Res Ther"},{"key":"383_CR99","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.jalz.2011.05.2351","volume":"7","author":"RA Sperling","year":"2011","unstructured":"Sperling RA, Jack CR, Black SE, Frosch MP, Greenberg SM, Hyman BT, et al. Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer\u2019s Association Research Roundtable Workgroup. Alzheimers Dement. 2011;7:367\u201385.","journal-title":"Alzheimers Dement"},{"key":"383_CR100","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S1474-4422(12)70015-7","volume":"11","author":"R Sperling","year":"2012","unstructured":"Sperling R, Salloway S, Brooks DJ, Tampieri D, Barakos J, Fox NC, et al. Amyloid-related imaging abnormalities in patients with Alzheimer\u2019s disease treated with bapineuzumab: a retrospective analysis. Lancet Neurol. 2012;11:241\u20139.","journal-title":"Lancet Neurol"},{"key":"383_CR101","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13024-024-00758-0","volume":"19","author":"X Taylor","year":"2024","unstructured":"Taylor X, Noristani HN, Fitzgerald GJ, Oluoch H, Babb N, McGathey T, et al. Amyloid-\u03b2 (A\u03b2) immunotherapy induced microhemorrhages are linked to vascular inflammation and cerebrovascular damage in a mouse model of Alzheimer\u2019s disease. Mol Neurodegener. 2024;19:77.","journal-title":"Mol Neurodegener"},{"key":"383_CR102","doi-asserted-by":"publisher","first-page":"6176","DOI":"10.1038\/ncomms7176","volume":"6","author":"C Condello","year":"2015","unstructured":"Condello C, Yuan P, Schain A, Grutzendler J. Microglia constitute a barrier that prevents neurotoxic protofibrillar A\u03b242 hotspots around plaques. Nat Commun. 2015;6:6176.","journal-title":"Nat Commun"},{"key":"383_CR103","first-page":"430","volume":"26","author":"H Zeng","year":"2023","unstructured":"Zeng H, Huang J, Zhou H, Meilandt WJ, Dejanovic B, Zhou Y, et al. Integrative in situ mapping of single-cell transcriptional states and tissue histopathology in a mouse model of Alzheimer\u2019s disease. Nat Neurosci. 2023;26:430\u201346.","journal-title":"Nat Neurosci"},{"key":"383_CR104","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114216","volume":"43","author":"A Mallach","year":"2024","unstructured":"Mallach A, Zielonka M, van Lieshout V, An Y, Khoo JH, Vanheusden M, et al. Microglia-astrocyte crosstalk in the amyloid plaque niche of an Alzheimer\u2019s disease mouse model, as revealed by spatial transcriptomics. Cell Rep. 2024;43: 114216.","journal-title":"Cell Rep"},{"key":"383_CR105","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1038\/s41586-024-07606-7","volume":"632","author":"H Mathys","year":"2024","unstructured":"Mathys H, Boix CA, Akay LA, Xia Z, Davila-Velderrain J, Ng AP, et al. Single-cell multiregion dissection of Alzheimer\u2019s disease. Nature. 2024;632:858\u201368.","journal-title":"Nature"},{"key":"383_CR106","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.1038\/s41588-024-01961-x","volume":"56","author":"E Miyoshi","year":"2024","unstructured":"Miyoshi E, Morabito S, Henningfield CM, Das S, Rahimzadeh N, Shabestari SK, et al. Spatial and single-nucleus transcriptomic analysis of genetic and sporadic forms of Alzheimer\u2019s disease. Nat Genet. 2024;56:2704\u201317.","journal-title":"Nat Genet"}],"container-title":["Inflammation and Regeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41232-025-00383-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41232-025-00383-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41232-025-00383-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T05:01:49Z","timestamp":1748581309000},"score":1,"resource":{"primary":{"URL":"https:\/\/inflammregen.biomedcentral.com\/articles\/10.1186\/s41232-025-00383-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,30]]},"references-count":106,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["383"],"URL":"https:\/\/doi.org\/10.1186\/s41232-025-00383-4","relation":{},"ISSN":["1880-8190"],"issn-type":[{"value":"1880-8190","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,30]]},"assertion":[{"value":"26 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors approved the manuscript and gave their consent for submission and publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16"}}